Peak6 Investments LLC Verve Therapeutics, Inc. Put Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$4.4 - $7.86 $110,000 - $196,500
25,000 New
25,000 $121,000
Q1 2024

May 14, 2024
BUY
$10.81 - $17.96 $216,200 - $359,200
20,000 New
20,000 $265,000
Q3 2023

Nov 13, 2023
BUY
$11.42 - $20.82 $1,142 - $2,082
100 New
100 $1,000
Q3 2022

Nov 14, 2022
BUY
$15.63 - $41.49 $87,528 - $232,344
5,600 New
5,600 $192,000

Others Institutions Holding VERV

# of Institutions
187
Shares Held
73.4M
Call Options Held
85K
Put Options Held
215K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $287M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email